BDBM402290 US10011627, 6

SMILES Cc1cc(O)c(cc1Cc1ccc2OCCOc2c1)[C@@H]1S[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O

InChI Key InChIKey=YPMZPLLIBZDQHJ-UHFFFAOYSA-N

Data  2 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 2 hits for monomerid = 402290   

TargetSodium/glucose cotransporter 1(Human)
Youngene Therapeutics

US Patent
LigandPNGBDBM402290(US10011627, 6)
Affinity DataIC50: 2.59nMAssay Description:The following method was used to determine the inhibitory activity of the compounds of the present invention on SGLT1 and SGLT2. The experimental met...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent

TargetSodium/glucose cotransporter 2(Human)
Youngene Therapeutics

US Patent
LigandPNGBDBM402290(US10011627, 6)
Affinity DataIC50: 99.9nMAssay Description:The following method was used to determine the inhibitory activity of the compounds of the present invention on SGLT1 and SGLT2. The experimental met...More data for this Ligand-Target Pair
In Depth
Date in BDB:
5/26/2020
Entry Details
US Patent